11 results on '"Mao, Xuehan"'
Search Results
2. The age-dependent changes in risk weights of the prognostic factors for multiple myeloma.
3. Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome.
4. 1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib.
5. Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.
6. The impact of response kinetics following initial therapy for multiple myeloma in the era of novel agents.
7. IgH translocations with undefined partners are associated with superior outcome in multiple myeloma patients.
8. The prognostic value of 1q21 gain does not rely on the copy numbers, clone size and concurrence with t(4;14).
9. Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.
10. Real-world Outcomes of Chinese patients with high-risk Multiple Myeloma.
11. Multiple high-risk cytogenetic aberrations confer a progressively negative impact on survivals of newly diagnosed myeloma patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.